Abstract
For many years, the majority of the observational and epidemiological studies assessing coronary artery disease patients, national and international clinical guidelines, registries and randomized trials have focused almost exclusively on men whereas women were usually excluded in most series. This underrepresentation of women in the medical literature in this field has resulted in few data being available regarding the clinical course of the condition, its management and clinical outcomes in this specific population, despite the relatively high prevalence of ischemic heart disease in women. The situation has changed -at least partially- in the past few years with publications focusing on this issue and reporting the existence of inequalities between genders regarding the diagnosis and treatment of coronary heart disease. This article will briefly review gender differences in the clinical presentation, diagnostic strategies and prognosis of coronary heart disease.
Keywords: Coronary artery disease, gender differences, diagnosis, management, epidemiological, nausea, electrocardiogram, angioplasty, pectoris, sotalol, therapeutic, pharmacotherapy, revascularization, proactive, prognostic, angina, invasive, microvascular
Current Pharmaceutical Design
Title: The Importance of Gender Differences in the Diagnosis and Management of Cardiovascular Disease
Volume: 17 Issue: 11
Author(s): Graciana Ciambrone and Juan Carlos Kaski
Affiliation:
Keywords: Coronary artery disease, gender differences, diagnosis, management, epidemiological, nausea, electrocardiogram, angioplasty, pectoris, sotalol, therapeutic, pharmacotherapy, revascularization, proactive, prognostic, angina, invasive, microvascular
Abstract: For many years, the majority of the observational and epidemiological studies assessing coronary artery disease patients, national and international clinical guidelines, registries and randomized trials have focused almost exclusively on men whereas women were usually excluded in most series. This underrepresentation of women in the medical literature in this field has resulted in few data being available regarding the clinical course of the condition, its management and clinical outcomes in this specific population, despite the relatively high prevalence of ischemic heart disease in women. The situation has changed -at least partially- in the past few years with publications focusing on this issue and reporting the existence of inequalities between genders regarding the diagnosis and treatment of coronary heart disease. This article will briefly review gender differences in the clinical presentation, diagnostic strategies and prognosis of coronary heart disease.
Export Options
About this article
Cite this article as:
Ciambrone Graciana and Carlos Kaski Juan, The Importance of Gender Differences in the Diagnosis and Management of Cardiovascular Disease, Current Pharmaceutical Design 2011; 17 (11) . https://dx.doi.org/10.2174/138161211795656945
DOI https://dx.doi.org/10.2174/138161211795656945 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Association between Paraoxonase 1(PON1) Gene Polymorphisms and PON1 Enzyme Activity in Indian Patients with Coronary Artery Disease (CAD)
Current Pharmacogenomics and Personalized Medicine Molecular Biological Roles of Ursolic Acid in the Treatment of Human Diseases
Current Bioactive Compounds Principles and Therapeutic Relevance for Targeting Mitochondria in Aging and Neurodegenerative Diseases
Current Pharmaceutical Design Haptoglobin Polymorphism and Lacunar Stroke
Current Neurovascular Research New Trends in Thromboxane and Prostacyclin Modulators
Current Medicinal Chemistry Current Perspectives on Anti-Aging Interventions
Letters in Drug Design & Discovery Targeting Heme Oxygenase-1 in Vascular Disease
Current Drug Targets Editorial (Thematic Issue: GPCR-Targeted Drug Development)
Current Drug Targets Minocycline Repurposing in Critical Illness: Focus on Stroke
Current Topics in Medicinal Chemistry On the Interaction Between Human IQGAP1 and Actin
Protein & Peptide Letters Diabetic Heart and the Cardiovascular Surgeon
Cardiovascular & Hematological Disorders-Drug Targets Biotransformation of Bioactive Natural Products for Pharmaceutical Lead Compounds
Current Organic Chemistry Novel Therapeutic Approaches in Rheumatoid Arthritis: Role of Janus Kinases Inhibitors
Current Medicinal Chemistry NADPH Oxidases in the Heart
Current Cardiology Reviews Some Developments Regarding Functional Food Products (Functional Foods)
Current Nutrition & Food Science Discovering Natural Product Modulators to Overcome Multidrug Resistance in Cancer Chemotherapy
Current Pharmaceutical Biotechnology Molecular Docking and Virtual Screening Based Prediction of Drugs for COVID-19
Combinatorial Chemistry & High Throughput Screening An Overview of Innovations in Analysis and Beneficial Health Effects of Wine Polyphenols
Mini-Reviews in Medicinal Chemistry An Experimental and Theoretical Approach to Understand Fever, DENF & its Cure
Infectious Disorders - Drug Targets The Role of Antiplatelet Therapy in Primary Prevention. A Review
Current Pharmaceutical Design